• 232 Citations
  • 6 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Yingjun Jiang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Ataxia Telangiectasia Medicine & Life Sciences
Drug Combinations Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
DNA Medicine & Life Sciences
DNA Repair Medicine & Life Sciences
Genomic Instability Medicine & Life Sciences
DNA-Activated Protein Kinase Medicine & Life Sciences
Topoisomerase II Inhibitors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2018

  • 232 Citations
  • 6 h-Index
  • 10 Article
2 Citations (Scopus)

Targeting BRCA1/2 deficient ovarian cancer with CNDAC-based drug combinations

Liu, X., Jiang, Y., Nowak, B., Qiang, B., Cheng, N., Chen, Y. & Plunkett Jr, W. K., Feb 1 2018, In : Cancer chemotherapy and pharmacology. 81, 2, p. 255-267 13 p.

Research output: Contribution to journalArticle

Drug Combinations
Ovarian Neoplasms
3 Citations (Scopus)
Ataxia Telangiectasia
B-Cell Chronic Lymphocytic Leukemia
Chromosomes, Human, Pair 1
2 Citations (Scopus)

Mechanism-based drug combinations with the DNA strand-breaking nucleoside analog CNDAC

Liu, X., Jiang, Y., Nowak, B., Hargis, S. & Plunkett Jr, W. K., Oct 1 2016, In : Molecular cancer therapeutics. 15, 10, p. 2302-2313 12 p.

Research output: Contribution to journalArticle

Drug Combinations
DNA Repair
Homologous Recombination
44 Citations (Scopus)

FANCM and FAAP24 Maintain Genome Stability via Cooperative as Well as Unique Functions

Wang, Y., Leung, J. W., Jiang, Y., Lowery, M. G., Do, H., Vasquez, K. M., Chen, J., Wang, W. & Li, L., Mar 7 2013, In : Molecular cell. 49, 5, p. 997-1009 13 p.

Research output: Contribution to journalArticle

Genomic Instability
Fanconi Anemia
DNA Damage
Sister Chromatid Exchange
11 Citations (Scopus)

Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients

Foglietta, M., Neelapu, S. S., Kwak, L. W., Jiang, Y., Nattamai, D., Lee, S. T., Fowler, D. H., Sportes, C., Gress, R. E., Steinberg, S. M., Vence, L. M., Radvanyi, L., Dwyer, K. C., Qazilbash, M. H., Bryant, R. N. K. & Bishop, M. R., Feb 1 2013, In : Bone marrow transplantation. 48, 2, p. 269-277 9 p.

Research output: Contribution to journalArticle

Homologous Transplantation
Neoplasm Antigens
Tissue Donors